ARTICLE | Clinical News
AmpliPhi BioSciences, Celladon preclinical data
August 5, 2013 7:00 AM UTC
In rat models of PAH, Mydicar administered through a nebulizer-like inhalation device completely reversed the disease. Data were published in Circulation. A single intracoronary infusion of the recomb...